CareDx Gross Margin 2013-2025 | CDNA

Current and historical gross margin for CareDx (CDNA) over the last 10 years. The current gross profit margin for CareDx as of March 31, 2025 is %.
CareDx Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2025-03-31 $0.35B $0.23B 67.15%
2024-12-31 $0.33B $0.22B 66.77%
2024-09-30 $0.31B $0.21B 65.50%
2024-06-30 $0.30B $0.19B 64.98%
2024-03-31 $0.28B $0.17B 62.91%
2023-12-31 $0.28B $0.18B 63.57%
2023-09-30 $0.30B $0.19B 64.53%
2023-06-30 $0.31B $0.20B 64.61%
2023-03-31 $0.32B $0.21B 65.20%
2022-12-31 $0.32B $0.21B 65.42%
2022-09-30 $0.32B $0.21B 65.72%
2022-06-30 $0.32B $0.21B 66.35%
2022-03-31 $0.31B $0.21B 66.88%
2021-12-31 $0.30B $0.20B 67.23%
2021-09-30 $0.28B $0.19B 67.75%
2021-06-30 $0.25B $0.17B 68.38%
2021-03-31 $0.22B $0.15B 67.87%
2020-12-31 $0.19B $0.13B 67.71%
2020-09-30 $0.17B $0.11B 66.86%
2020-06-30 $0.15B $0.10B 65.33%
2020-03-31 $0.14B $0.09B 65.47%
2019-12-31 $0.13B $0.08B 63.78%
2019-09-30 $0.12B $0.07B 61.74%
2019-06-30 $0.10B $0.06B 59.80%
2019-03-31 $0.09B $0.05B 58.43%
2018-12-31 $0.08B $0.04B 57.14%
2018-09-30 $0.07B $0.04B 57.58%
2018-06-30 $0.06B $0.03B 57.89%
2018-03-31 $0.05B $0.03B 56.86%
2017-12-31 $0.05B $0.03B 55.10%
2017-09-30 $0.05B $0.02B 51.06%
2017-06-30 $0.05B $0.02B 51.06%
2017-03-31 $0.05B $0.02B 47.83%
2016-12-31 $0.04B $0.02B 48.78%
2016-09-30 $0.04B $0.02B 54.05%
2016-06-30 $0.03B $0.02B 56.25%
2016-03-31 $0.03B $0.02B 64.29%
2015-12-31 $0.03B $0.02B 67.86%
2015-09-30 $0.03B $0.02B 72.41%
2015-06-30 $0.03B $0.02B 72.41%
2015-03-31 $0.03B $0.02B 68.97%
2014-12-31 $0.03B $0.02B 67.86%
2014-09-30 $0.03B $0.02B 65.38%
2014-06-30 $0.03B $0.02B 60.00%
2014-03-31 $0.02B $0.01B 60.87%
2013-12-31 $0.02B $0.01B 59.09%
Sector Industry Market Cap Revenue
Medical Medical Services $1.149B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $147.077B 27.58
CVS Health (CVS) United States $83.011B 10.32
Elevance Health (ELV) United States $78.142B 10.08
Cencora (COR) United States $57.628B 20.05
DiDi Global (DIDIY) China $23.768B 25.25
Natera (NTRA) United States $22.306B 0.00
Labcorp Holdings (LH) United States $21.229B 17.22
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.751B 0.00
Solventum (SOLV) United States $13.128B 13.90
CochLear (CHEOY) Australia $12.788B 0.00
ICON (ICLR) Ireland $12.281B 11.42
Revvity (RVTY) United States $12.070B 20.77
Viatris (VTRS) United States $10.857B 3.73
Medpace Holdings (MEDP) United States $9.434B 25.06
Avantor (AVTR) United States $9.336B 13.56
Sonic Healthcare (SKHHY) Australia $8.582B 0.00
HealthEquity (HQY) United States $8.405B 36.81
Charles River Laboratories (CRL) United States $8.038B 15.75
Caris Life Sciences,�Inc (CAI) United States $6.772B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $5.024B 29.58
BrightSpring Health Services (BTSG) United States $3.667B 33.65
Sotera Health (SHC) United States $3.375B 19.18
Surgery Partners (SGRY) United States $2.855B 37.12
Alignment Healthcare (ALHC) United States $2.647B 0.00
Concentras Parent (CON) United States $2.621B 15.15
Organon (OGN) United States $2.605B 2.77
GeneDx Holdings (WGS) United States $2.480B 95.51
Ardent Health (ARDT) United States $2.041B 8.70
Progyny (PGNY) United States $2.024B 44.55
PACS (PACS) United States $1.949B 0.00
Premier (PINC) United States $1.767B 13.41
GoodRx Holdings (GDRX) United States $1.750B 35.00
Teladoc Health (TDOC) United States $1.546B 0.00
Establishment Labs Holdings (ESTA) $1.329B 0.00
Pediatrix Medical (MD) United States $1.160B 8.82
Ryman Healthcare (RYHTY) New Zealand $0.970B 0.00
Agilon Health (AGL) United States $0.956B 0.00
AMN Healthcare Services Inc (AMN) United States $0.846B 7.92
QDM (QDMI) Hong Kong, SAR China $0.846B 290.00
Nutex Health (NUTX) United States $0.653B 9.89
Embecta (EMBC) United States $0.627B 4.22
InnovAge Holding (INNV) United States $0.567B 0.00
SBC Medicals (SBC) United States $0.552B 0.00
LifeMD (LFMD) United States $0.544B 0.00
Sonida Senior Living (SNDA) United States $0.486B 0.00
Auna S.A (AUNA) Luxembourg $0.471B 10.60
Omada Health (OMDA) $0.461B 0.00
So-Young (SY) China $0.389B 0.00
Enhabit (EHAB) United States $0.375B 30.88
COMPASS Pathways (CMPS) United Kingdom $0.348B 0.00
Performant Healthcare (PHLT) United States $0.338B 0.00
Beauty Health (SKIN) United States $0.257B 0.00
Oncology Institute (TOI) United States $0.256B 0.00
DocGo (DCGO) United States $0.153B 25.00
Pheton Holdings (PTHL) China $0.134B 0.00
Sera Prognostics (SERA) United States $0.104B 0.00
KindlyMD (NAKA) United States $0.080B 0.00
Ascend Wellness Holdings (AAWH) United States $0.079B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.059B 0.00
Basel Medical Group (BMGL) Singapore $0.055B 0.00
ModivCare (MODV) United States $0.054B 0.00
Biodesix (BDSX) United States $0.045B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.037B 0.00
OSR Holdings (OSRH) United States $0.023B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.011B 0.00
Co-Diagnostics (CODX) United States $0.008B 0.00
SeaStar Medical Holding (ICU) United States $0.007B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00